Efrem Kamen, Managing Member of Pura Vida Investments, invests exclusively in the global healthcare sector across. See sector focus and contact routes.
Efrem Kamen, Managing Member of Pura Vida Investments, invests exclusively in the global healthcare sector across biotechnology, medical devices, pharmaceuticals, and life sciences tools, targeting structural shifts and valuation inflections as his distinctive thesis. The firm employs a fundamentally driven, market-neutral strategy and invests across all stages from seed to late stage, with check sizes ranging from $1 million to $50 million. Notable portfolio companies include Imperative Care (Series E), Freenome, Beta Bionics, Alphatec, and Evaxion Biotech. While classified as venture capital by some sources, Pura Vida primarily operates as a hedge fund managing both public and private vehicles with approximately $91.5 million in assets under management.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in New York when building a target list.
Investors like Efrem Kamen · Full investor directory · Investor access · Company funding database